Evidence map›Paper›PMID 38706363›Full record

ReviewCurrent drug research reviews2025

Synergistic Outcomes in Drug Delivery: Exploring Harmonious Architectures of Interpenetrating Polymer Networks.

Samriddhi Bali, Shubhdeep Singh Bandral, Mohit Kumar, Ankush Saini, Rajan Swami

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug research reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samriddhi BaliChitkara College of Pharmacy, Chitkara University, Punjab, India.
Shubhdeep Singh BandralChitkara College of Pharmacy, Chitkara University, Punjab, India.
Mohit KumarDepartment of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University (MRSPTU), Bathinda, 151001, Punjab, India.
Ankush SainiMaharishi Markandeshwar College of Pharmacy, Maharishi Markandeshwar University, Mullana, India.
Rajan SwamiChitkara College of Pharmacy, Chitkara University, Punjab, India.ORCID 0000-0001-6291-3807

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical excipients play a crucial role in determining the outcome of delivered therapeutic cargo density. By far, polymers have captured the biggest share in the excipients market. This surge in demand motivated researchers to look for newer and novel polymeric platforms. Interpenetrating polymeric networks (IPN) are a class of polymer in the same polymer blend league, where two different polymer chains penetrate; and align with each other without any sustainable covalent bond. The novel agreement between the polymer chains equips the IPN with the characteristic features of each participating polymer unit, thus making IPN superior to its predecessors. IPN has crossed a long path, especially in the pharmaceutical medicine field, from the mere coinage of the term to widespread usage, especially in drug delivery, where they increased the bioavailability and efficacy of the co-delivered drugs. The current review will highlight the major studies that have led to the current face of the IPN in various pharmaceutical domains. The present review was conducted by comprehensively reviewing published reports within the recent period using multiple keywords related to IPN and its role in drug delivery. Moving forward, continued exploration and innovation in IPN technologies promise to further enhance their applications, offering novel solutions for the challenges in drug delivery and therapeutic cargo density.

Indexed as

Drug Delivery SystemsPolymersAnimalsExcipientsHumansPharmaceutical PreparationsExcipientsPharmaceutical PreparationsPolymerscovalent bond.Drug dosage formhydrogelinterpenetrating polymeric networknanoparticlespharmaceutical

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.